Mar 29, 2017

FDA approves revolutionary multiple sclerosis treatment

Rajiv Patel / Flickr Creative Commons

The FDA has approved Ocrevus, a new multiple sclerosis drug from Genentech, with a list price of $65,000 annually, per the WSJ.

This is the first drug approved to treat primary progressive MS, the more severe form of MS that affects 15% of patients. The president of the National MS Society called the treatment "a real game-changer" for those suffering from the disease.

Go deeper

Coronavirus death toll tops 2,000

Data: The Center for Systems Science and Engineering at Johns Hopkins, the CDC, and China's NHC; Note: China refers to mainland China and the Diamond Princess is the cruise ship offshore Yokohama, Japan. Map: Danielle Alberti/Axios

Some economists warn the stock market has been too "complacent" without factoring in the novel coronavirus as a valid risk, although the major averages were broadly lower midday Monday. Apple and Nvidia have issued earnings warnings and multiple conferences and sports events are being canceled or limited in size.

The big picture: COVID-19 has now killed at least 2,009 people and infected more than 75,000 others, mostly in mainland China. 328 American evacuees from the Diamond Princess are in quarantine at U.S. military bases after arriving from Japan, including 14 people who tested positive — making the total number of confirmed cases in the U.S. 29.

Go deeperArrowUpdated 5 mins ago - Health

Sanders requests recount of Iowa recanvass after results show shrunken margin

Photo: Joe Raedle/Getty Images.

Sen. Bernie Sanders said in a statement Tuesday night he will request a recount of the Iowa Democratic Party's recanvass results.

Where it stands: Both Buttigieg and Sanders requested partial recanvasses in Iowa last week after results were delayed and showed several errors following a software malfunction on caucus night.

Axios Dashboard

Keep up with breaking news throughout the day — sign up for our alerts.